Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.7 (Beat by $0.01) |
EPS GAAP Actual | $0.7 (Beat by $0.01) |
Revenue Actual | $20.175B |
Revenue Surprise | Beat by $20175M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.41358 |
EPS GAAP Estimate | $1.41358 |
Revenue Estimate | $24.84293896B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.005 | 11.05 | 4.23 | 5.78 | 2 |
Dec 2026 | 5.48954 | 10.08 | 4.57 | 6.18 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.61 | -0.72837 | 20.175B | -8.28% | -3893.31M |
FQ4 2024 (Dec 2024) | 1.17 | 1.17 | 21.498B | -6.92% | 21498M |
FQ3 2024 (Sep 2024) | 0.0373 | 0.0373 | 19.937B | -8.82% | 19937M |
FQ2 2024 (Jun 2024) | 0.99 | 0.99 | 22.248B | -13.22% | 22248M |
FQ1 2024 (Mar 2024) | 1.42 | 1.42 | 21.846B | -10.19% | 21846M |
FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 22.986B | -14.12% | 22986M |
FQ3 2023 (Sep 2023) | 1.52 | 1.52 | 21.695B | -13.77% | 21695M |
FQ2 2023 (Jun 2023) | 1.7 | 1.7 | 25.19B | 100% | 25190M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.41358
Consensus Revenue Estimates
24.84293896B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.3948 | -- | 1.32253 | 1.42897 | 1 |
FQ2 2027 (Jun 2027) | 1.5132 | -- | 1.4348 | 1.55027 | 1 |
FQ1 2027 (Mar 2027) | 1.3697 | -- | 1.30869 | 1.40826 | 1 |
FQ4 2026 (Oct 2026) | 1.42308 | -- | 1.2526 | 1.60944 | 3 |
FQ3 2026 (Jul 2026) | 1.45381 | -- | 1.27965 | 1.6442 | 5 |
FQ2 2026 (Jun 2026) | 1.62139 | -- | 1.32615 | 1.80237 | 5 |
FQ1 2026 (Mar 2026) | 1.45205 | 57.99 | 1.18764 | 1.61413 | 3 |
FQ4 2025 (Oct 2025) | 1.42908 | 18.13 | 1.25788 | 1.61623 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 21.4B | -- | 20.55B | 21.81B | 2 |
FQ2 2027 (Jun 2027) | 23.82B | -- | 22.87B | 24.27B | 2 |
FQ1 2027 (Mar 2027) | 20.56B | -- | 19.85B | 21B | 2 |
FQ4 2026 (Oct 2026) | 27.28B | -- | 24.76B | 30.02B | 4 |
FQ3 2026 (Jul 2026) | 27.21B | -- | 24.7B | 29.95B | 5 |
FQ2 2026 (Jun 2026) | 25.97B | -- | 22.34B | 28.2B | 5 |
FQ1 2026 (Mar 2026) | 25.83B | 21.9 | 22.22B | 28.05B | 6 |
FQ4 2025 (Oct 2025) | 23.07B | 6.83 | 20.95B | 25.4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.33837 | 0.61 | -0.72837 | -119.4% |
FQ4 2024 (Dec 2024) | 1.17 | 1.17 | 100% | |
FQ3 2024 (Sep 2024) | 0.0373 | 0.0373 | 100% | |
FQ2 2024 (Jun 2024) | 0.99 | 0.99 | 100% | |
FQ1 2024 (Mar 2024) | 1.42 | 1.42 | 100% | |
FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 100% | |
FQ3 2023 (Sep 2023) | 1.52 | 1.52 | 100% | |
FQ2 2023 (Jun 2023) | 1.7 | 1.7 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $24.07B | $20.18B | $-3893.31M | -19.3% |
FQ4 2024 (Dec 2024) | $0B | $21.5B | $21498M | 100% |
FQ3 2024 (Sep 2024) | $0B | $19.94B | $19937M | 100% |
FQ2 2024 (Jun 2024) | $0B | $22.25B | $22248M | 100% |
FQ1 2024 (Mar 2024) | $0B | $21.85B | $21846M | 100% |
FQ4 2023 (Dec 2023) | $0B | $22.99B | $22986M | 100% |
FQ3 2023 (Sep 2023) | $0B | $21.7B | $21695M | 100% |
FQ2 2023 (Jun 2023) | $0B | $25.19B | $25190M | 100% |